The Clinical Significance of Quantitative HBSAG in Patients With HBEAG Negative Chronic Hepatitis B

Acta Medica Saliniana - Bosnia and Herzegovina
doi 10.5457/ams.v49i2.517
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

University Clinical Centre Tuzla

Related search

IL28B Polymorphism Correlates With Active Hepatitis in Patients With HBeAg-Negative Chronic Hepatitis B

PLoS ONE
Multidisciplinary
2013English

HBV DNA Suppression and HBsAg Clearance in HBeAg Negative Chronic Hepatitis B Patients on Lamivudine Therapy for Over 5years

Journal of Hepatology
Hepatology
2012English

Significance of Definitions of Relapse After Discontinuation of Oral Antivirals in HBeAg-negative Chronic Hepatitis B

Hepatology
MedicineHepatology
2018English

Treatment of HBeAg-Negative Chronic Hepatitis B Patients With Nucleos(t)ide Analogues in Burkina Faso

Open Journal of Gastroenterology
2016English

Vitamin D-Binding Protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study

Asian Pacific Journal of Cancer Prevention
2019English

Correlation of Hepatitis B Virus Viral Load and HBeAg Status in HBsAg Positive Patients

Asian Journal of Pharmacy and Pharmacology
2019English

Immunoelectron Microscopic Observation of HBeAg in Hepatocytes of Patients With Chronic Hepatitis B.

Acta Hepatologica Japonica
Hepatology
1989English

Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients With Elevated Hepatitis B Virus DNA Levels

PLoS ONE
Multidisciplinary
2015English

Baltic Post-Marketing Study of Pegilated Interferon Α-2a 40 KD Efficacy and Safety in Patients With HBeAg–Positive and HBeAg – Negative Chronic Hepatitis B

Virology & Mycology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy